Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph Rubin

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 16, 2002
A Phase I study of bizelesin (NSC 615291) in patients with advanced solid tumorsHenry C Pitot, Joel M Reid, Jeff A Sloan, et al.
Oncology Nursing Forum|November 7, 2003
Stories of breast cancer through artJulie A Ponto, Marlene H Frost, Romayne Thompson, et al.
Clinical Colorectal Cancer|July 7, 2011
Hepatic arterial infusion and systemic chemotherapy after multiple metastasectomy in patients with colorectal carcinoma metastatic to the liver: a North Central Cancer Treatment Group (NCCTG) phase II study, 92-46-52John S Bolton, Michael J O'Connell, Michelle R Mahoney, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2003
Phase I and pharmacokinetic study of two different schedules of oxaliplatin, irinotecan, Fluorouracil, and leucovorin in patients with solid tumorsMatthew P Goetz, Charles Erlichman, Anthony J Windebank, et al.
Cancer|November 2, 2004
Intratumoral administration of a 1,2-dimyristyloxypropyl-3- dimethylhydroxyethyl ammonium bromide/dioleoylphosphatidylethanolamine formulation of the human interleukin-2 gene in the treatment of metastatic renal cell carcinomaEvanthia Galanis, Patrick A Burch, Ronald L Richardson, et al.
Investigational New Drugs|September 15, 2010
An international, multicenter phase II trial of bortezomib in patients with hepatocellular carcinomaGeorge P Kim, Michelle R Mahoney, Daniel Szydlo, et al.
Radiology|October 24, 2006
Painful metastases involving bone: percutaneous image-guided cryoablation--prospective trial interim analysisMatthew R Callstrom, Thomas D Atwell, J William Charboneau, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2002
Comparative pharmacokinetic study of continuous venous infusion fluorouracil and oral fluorouracil with eniluracil in patients with advanced solid tumorsAlex A Adjei, Joel M Reid, Robert B Diasio, et al.
Cancer Chemotherapy and Pharmacology|March 9, 2005
A phase IB study of the pharmacokinetics of gemcitabine and pemetrexed, when administered in rapid sequence to patients with advanced solid tumorsGrace K Dy, Ajit Suri, Joel M Reid, et al.
Cancer Chemotherapy and Pharmacology|December 6, 2005
A phase I and pharmacokinetic study of a powder-filled capsule formulation of oral irinotecan (CPT-11) given daily for 5 days every 3 weeks in patients with advanced solid tumorsHenry C Pitot, Alex A Adjei, Joel M Reid, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 16, 2002
A Phase I study of bizelesin (NSC 615291) in patients with advanced solid tumorsHenry C Pitot, Joel M Reid, Jeff A Sloan, et al.
Oncology Nursing Forum|November 7, 2003
Stories of breast cancer through artJulie A Ponto, Marlene H Frost, Romayne Thompson, et al.
Clinical Colorectal Cancer|July 7, 2011
Hepatic arterial infusion and systemic chemotherapy after multiple metastasectomy in patients with colorectal carcinoma metastatic to the liver: a North Central Cancer Treatment Group (NCCTG) phase II study, 92-46-52John S Bolton, Michael J O'Connell, Michelle R Mahoney, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2003
Phase I and pharmacokinetic study of two different schedules of oxaliplatin, irinotecan, Fluorouracil, and leucovorin in patients with solid tumorsMatthew P Goetz, Charles Erlichman, Anthony J Windebank, et al.
Cancer|November 2, 2004
Intratumoral administration of a 1,2-dimyristyloxypropyl-3- dimethylhydroxyethyl ammonium bromide/dioleoylphosphatidylethanolamine formulation of the human interleukin-2 gene in the treatment of metastatic renal cell carcinomaEvanthia Galanis, Patrick A Burch, Ronald L Richardson, et al.
Investigational New Drugs|September 15, 2010
An international, multicenter phase II trial of bortezomib in patients with hepatocellular carcinomaGeorge P Kim, Michelle R Mahoney, Daniel Szydlo, et al.
Radiology|October 24, 2006
Painful metastases involving bone: percutaneous image-guided cryoablation--prospective trial interim analysisMatthew R Callstrom, Thomas D Atwell, J William Charboneau, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2002
Comparative pharmacokinetic study of continuous venous infusion fluorouracil and oral fluorouracil with eniluracil in patients with advanced solid tumorsAlex A Adjei, Joel M Reid, Robert B Diasio, et al.
Cancer Chemotherapy and Pharmacology|March 9, 2005
A phase IB study of the pharmacokinetics of gemcitabine and pemetrexed, when administered in rapid sequence to patients with advanced solid tumorsGrace K Dy, Ajit Suri, Joel M Reid, et al.
Cancer Chemotherapy and Pharmacology|December 6, 2005
A phase I and pharmacokinetic study of a powder-filled capsule formulation of oral irinotecan (CPT-11) given daily for 5 days every 3 weeks in patients with advanced solid tumorsHenry C Pitot, Alex A Adjei, Joel M Reid, et al.
Pageof 5